[{"Assets_0_Q2_USD":23952900000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":2556400000.0,"NetIncomeLoss_1_Q2_USD":866600000.0,"NetIncomeLoss_2_Q2_USD":2039500000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":207300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":209500000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":207100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":209200000.0,"StockholdersEquity_0_Q2_USD":12260900000.0,"EarningsPerShareBasic_1_Q2_USD":4.18,"EarningsPerShareBasic_2_Q2_USD":9.75,"EarningsPerShareDiluted_1_Q2_USD":4.18,"EarningsPerShareDiluted_2_Q2_USD":9.73,"Ticker":"BIIB","CIK":"875045","name":"BIOGEN INC.","OfficialName":"Biogen Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"32775642095.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20180724"}]